Performance in population models for count data, part I: maximum likelihood approximations
暂无分享,去创建一个
Mats O. Karlsson | Elodie L. Plan | Iñaki F. Trocóniz | Alan Maloney | M. Karlsson | I. Trocóniz | E. Plan | A. Maloney
[1] N. Breslow,et al. Bias Correction in Generalized Linear Mixed Models with Multiple Components of Dispersion , 1996 .
[2] Mats O. Karlsson,et al. Modelling overdispersion and Markovian features in count data , 2009, Journal of Pharmacokinetics and Pharmacodynamics.
[3] John P Elder,et al. Epidemiologic Perspectives & Innovations Open Access a Demonstration of Modeling Count Data with an Application to Physical Activity , 2022 .
[4] L B Sheiner,et al. Experience with NONMEM: analysis of routine phenytoin clinical pharmacokinetic data. , 1984, Drug metabolism reviews.
[5] Lewis B. Sheiner,et al. Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data , 1981, Journal of Pharmacokinetics and Biopharmaceutics.
[6] Siv Jönsson,et al. Estimating Bias in Population Parameters for Some Models for Repeated Measures Ordinal Data Using NONMEM and NLMIXED , 2004, Journal of Pharmacokinetics and Pharmacodynamics.
[7] Lewis B. Sheiner,et al. Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic data , 1983, Journal of Pharmacokinetics and Biopharmaceutics.
[8] Noreen Goldman,et al. An assessment of estimation procedures for multilevel models with binary responses , 1995 .
[9] Evaluation of Mixture Modeling with Count Data Using NONMEM , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[10] R. Savic,et al. Pharmacokinetics of Desmopressin Administrated as an Oral Lyophilisate Dosage Form in Children With Primary Nocturnal Enuresis and Healthy Adults , 2006, Journal of clinical pharmacology.
[11] R. Winkelmann,et al. Count data models for demographic data. , 1994, Mathematical population studies.
[12] James W Hardin,et al. Testing Approaches for Overdispersion in Poisson Regression versus the Generalized Poisson Model , 2007, Biometrical journal. Biometrische Zeitschrift.
[13] M O Karlsson,et al. Diagnosing Model Diagnostics , 2007, Clinical pharmacology and therapeutics.
[14] L B Sheiner,et al. Quantitative characterization of therapeutic index: Application of mixed‐effects modeling to evaluate oxybutynin dose–efficacy and dose–side effect relationships , 1999, Clinical pharmacology and therapeutics.
[15] N H Holford,et al. Simulation of clinical trials. , 2000, Annual review of pharmacology and toxicology.
[16] Yaning Wang. Derivation of various NONMEM estimation methods , 2007, Journal of Pharmacokinetics and Pharmacodynamics.
[17] Sylvie Chabaud,et al. Clinical Trial Simulation Using Therapeutic Effect Modeling: Application to Ivabradine Efficacy in Patients with Angina Pectoris , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[18] Lewis B. Sheiner,et al. Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data , 1980, Journal of Pharmacokinetics and Biopharmaceutics.
[19] M. Puterman,et al. Mixed Poisson regression models with covariate dependent rates. , 1996, Biometrics.